Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
106.00    -3.00 (-2.75%)
Bid:
105.00
Ask:
107.00
Spread: 2.00 (1.905%)
Market Cap: £104.46m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Director/PDMR Shareholding

26 Apr 2021 09:40

RNS Number : 5698W
Eurocell plc
26 April 2021
Β 

26 April 2021

Β 

Eurocell plc

Β 

Director/PDMR Shareholding

Β 

Eurocell plc (theΒ "Company") announces that, on 22 April 2021, options were granted under the Eurocell plc Performance Share Plan 2015 to 2 directors.

Β 

The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mark Kelly

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of Β£0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of a nil-cost option to acquire ordinary shares under the Eurocell plc Performance Share Plan 2015

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£nil (option price)

234,362

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

Β 

Β 

N/A - single transaction

e)

Date of the transaction

22 April 2021

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Michael Scott

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of Β£0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of a nil-cost option to acquire ordinary shares under the Eurocell plc Performance Share Plan 2015

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£nil (option price)

149,731

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

Β 

Β 

N/A - single transaction

e)

Date of the transaction

22 April 2021

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

For further information:

Β 

Eurocell plc 01773 842 100

Paul Walker

Group Company Secretary

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPPUBWCUPGURQ
Date   Source Headline
16th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
7th Mar 20237:00 amRNSBlock listing Interim Review
3rd Feb 20237:00 amRNSNon-executive Directors' Share Purchase Plan
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSYear End Trading Update
6th Jan 20237:00 amRNSCEO Announces Intention to Retire in 2023
15th Nov 20227:04 amRNSHolding(s) in Company
14th Nov 20227:00 amRNSHolding(s) in Company
10th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:59 pmRNSDirectorate Change
26th Oct 20227:00 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSChanges to Board Committee memberships
5th Oct 20222:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSTotal Voting Rights
5th Sep 20227:00 amRNSBlock listing Interim Review
5th Sep 20227:00 amRNSInvestor Presentation
1st Sep 20227:00 amRNSHalf-year Report
15th Aug 20223:00 pmRNSHolding(s) in Company
10th Aug 20223:45 pmRNSAppointment to the Audit & Risk Committee
13th Jul 20227:00 amRNSTrading Update
5th Jul 202212:25 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
21st Jun 202212:08 pmRNSDirectorate Change
25th May 20227:00 amRNSBlock Listing Application
16th May 20227:00 amRNSDirector/PDMR Shareholding
12th May 20224:00 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update and Board Update
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
14th Apr 20224:00 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
21st Mar 20227:00 amRNSInvestor Presentation
18th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Mar 20227:00 amRNSNotice of Results and Audiocast
15th Mar 20223:05 pmRNSTransaction in Own Shares
9th Mar 20225:00 pmRNSBlock listing Interim Review
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
21st Jan 20227:00 amRNSYear End Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTotal Voting Rights
24th Nov 20217:00 amRNSTrading Update November 2021
1st Nov 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTotal Voting Rights
7th Sep 20214:00 pmRNSInvestor Presentation
7th Sep 20211:38 pmRNSBlock listing Interim Review
3rd Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20217:00 amRNSTrading Update
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.